Page 10 - Devanshu Singla

Phillip Capital starts with 'Buy' on SRM Contractors; sees up to 61% upside

According to Phillip Capital, SRM has proven execution capabilities in roads, bridges, tunnels, and slope stabilisation across the extreme terrains of Jammu & Kashmir and Ladakh

JM Financial initiates coverage on Thermax with 'Reduce' rating; check TP

JM Financial has initiated coverage on Thermax with a 'Reduce' rating and a sum-of-the-parts target price of ₹2,700

Equirus Securities starts coverage on IndiGo with 'Long'; check target

Equirus Securities has initiated coverage on budget-carrier InterGlobe Aviation (IndiGo) with a 'Long' rating, citing India's entry into a multi-decade aviation growth phase

Sona BLW Precision jumps 6% post Q3 results; what should investors do?

Sona BLW Precision reported profit after tax of ₹150.7 crore in Q3FY26, down marginally 0.3 per cent year-on-year from ₹151.2 crore in the year-ago period

Shadowfax Tech IPO opens Jan 20: 5 key strengths investors must know

Shadowfax Technologies comprises a fresh issue of 80.6 shares worth up to ₹1,000 crore, and an OFS of 73.2 million shares worth up to ₹907.27 crore

Stocks to Watch today, Jan 16: RIL, Infosys, ICICI Pru AMC, Jio Financial

Stocks to watch on January 16, 2026: Stocks like Infosys, ICICI Prudential AMC, Biocon, Angel One and HDB Financial Services will remain in focus today

Infosys stock to open higher on Friday? ADR jumps 10%; FY26 guidance raised

Infosys ADRs surged 10.2 per cent in New York on Wednesday after the company raised its revenue growth guidance for FY26 to 3-3.5 per cent from 2-3 per cent earlier

Nomura initiates Buy on Indian Hotels; cites ADR growth, asset-light model

Nomura has set a target price of ₹830 for the Indian Hotels stock, based on a valuation of 26 times its estimated FY28 EV/Ebitda

Stocks to Watch today, Jan 14: Infosys, ICICI Lombard, Tata Elxsi, IOB

Stocks to watch on January 14, 2026: Stocks like Infosys, ICICI Prudential Asset Management, Union Bank of India, ICICI Lombard General Insurance Company, Tata Elxsi and 5paisa Capital will remain in

Motilal Oswal starts coverage on Canara HSBC Life with 'Buy'; check target

Canara HSBC Life is among India's top 10 life insurance companies and has a well-diversified product mix, MOFSL said

Amagi Media vs Bharat Coking Coal IPO: Where should you put your money?

Bharat Coking Coal is witnessing strong interest, with its unlisted shares trading at ₹33.7, a premium of ₹10.7 or 46.5 per cent over the upper price band of ₹23.

Stocks to Watch today, Jan 13: TCS, HCL Tech, Anand Rathi Wealth, Biocon

Stocks to watch on January 13, 2026: Stocks like TCS, HCL Technologies, Anand Rathi Wealth, Biocon and NBCC will remain in focus today

Systematix bullish on water EPC; initiates 'Buy' on VA Tech Wabag, EIEL

Systematix has set a target price of ₹1,840 for VA Tech Wabag, implying an upside of 53 per cent, and ₹346 for Enviro Infra Engineers, indicating an 83 per cent potential gain

Bharat Coking Coal IPO 23x booked on strong demand; should you bid too?

Analysts are positive on Bharat Coking Coal, citing its market dominance, stable cash flows, and planned capacity expansions

Stocks to Watch today, Jan 12: TCS, HCL Tech, DMart, Ireda, Vedanta

Stocks to watch on January 12, 2026: Stocks like TCS, HCL Technologies, Anand Rathi Wealth, and Infibeam Avenues will remain in focus as they will release their quarterly earnings today.

HDFC Securities maintains 'Add' on Birla Corp; flags near-term volume dip

HDFC Securities has lowered its Ebitda estimates for Birla Corp for FY26-28E by 6 per cent, 9 per cent and 4 per cent, respectively, to account for near-term pricing pressure in Q3FY26

Elara Capital expects strong Q3 for Ports & Logistics cos; check top picks

Elara Capital has given a Buy rating to its top ports and logistics picks, including Adani Ports & SEZ, JSW Infrastructure and Delhivery

Motilal Oswal sees higher Q3 profits for Oil & Gas cos; RIL, OMCs to lead

Motilal Oswal expects its coverage universe to report a 4 per cent Y-o-Y decline in sales in Q3FY26, while Ebitda and PAT are projected to grow 16 per cent and 25 per cent Y-o-Y

Antique maintains 'Buy' on Concord Biotech; sees strong API, CDMO growth

Antique expects the Concord to report revenue, Ebitda and PAT CAGR of 18 per cent, 17 per cent and 19 per cent, respectively, with margins remaining stable at around 42 per cent over FY25-28E

Why does Elara Capital prefer fertilisers over agrochemicals? Top bets here

Elara Capital continues to prefer fertiliser companies over their agrochemical counterparts due to several growth opportunities offered by the sector without any meaningful risk